To determine the changes in immune parameters of COVID-19 patients, we compared lymphocyte, CD3+CD4+T cell, CD3+CD8+T cell, CD19+B cell, CD16+CD56+NK cell count and CD4+T/CD8+T ratio between the date of hospital discharge and hospital admission or death in survivors and non-survivors. This evidence concerns the gene CD8A and COVID-19.